Cargando…

CON: Carbapenems are NOT necessary for all infections caused by ceftriaxone-resistant Enterobacterales

Carbapenems are considered the drugs of choice for the treatment of serious infections caused by ceftriaxone-resistant Enterobacterales. However, because of the dramatic increase in carbapenem-resistant organisms worldwide, finding alternatives to carbapenems is a must. The potential options include...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Baño, Jesús, Gutiérrez-Gutiérrez, Belén, Pascual, Alvaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	For Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210108/ https://www.ncbi.nlm.nih.gov/pubmed/34223064 http://dx.doi.org/10.1093/jacamr/dlaa112

Ejemplares similares

PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales
por: Paterson, David L, et al.
Publicado: (2021)

CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales
por: Mathers, Amy J, et al.
Publicado: (2021)

PRO: Testing for ESBL production is necessary for ceftriaxone-non-susceptible Enterobacterales: perfect should not be the enemy of progress
por: Tamma, Pranita D, et al.
Publicado: (2021)

Extended‐spectrum β‐lactamase‐producing and carbapenem‐resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches
por: Pérez‐Nadales, Elena, et al.
Publicado: (2022)

Should ceftriaxone-resistant Enterobacterales be tested for ESBLs? A PRO/CON debate
por: Villegas, Maria Virginia, et al.
Publicado: (2021)

Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)
por: Pérez-Galera, Salvador, et al.
Publicado: (2023)

The necessary shift from diagnostic to prognostic research
por: Dinant, Geert-Jan GJ, et al.
Publicado: (2007)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
por: Lim, Fang Kang, et al.
Publicado: (2020)

The necessary future of chiropractic education: a North American perspective
por: Wyatt, Lawrence H, et al.
Publicado: (2005)

Skin antiseptics in healthcare facilities: is a targeted approach necessary?
por: Wiemken, Timothy L.
Publicado: (2019)

Pharmacogenomic technologies: a necessary "luxury" for better global public health?
por: Olivier, Catherine, et al.
Publicado: (2011)

Activity of mecillinam against carbapenem-resistant Enterobacterales
por: Emeraud, Cécile, et al.
Publicado: (2022)

Updates on the Status of Carbapenem-Resistant Enterobacterales in Lebanon
por: Fadlallah, Mahdi, et al.
Publicado: (2023)

Poor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales
por: Howard-Anderson, Jessica R., et al.
Publicado: (2022)

An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant Enterobacterales
por: Rabaan, Ali A., et al.
Publicado: (2022)

Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant Enterobacterales
por: Kaye, Keith S., et al.
Publicado: (2023)

EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA): a protocol of a European multicentre observational study
por: Gutiérrez-Gutiérrez, Belén, et al.
Publicado: (2017)

Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing Enterobacterales and Differentiation of Carbapenem-Resistant Enterobacterales
por: Takei, Kentarou, et al.
Publicado: (2023)

Identification and infection control of carbapenem-resistant Enterobacterales in intensive care units
por: Yi, Jongyoun, et al.
Publicado: (2021)

The carbapenem inoculum effect provides insight into the molecular mechanisms underlying carbapenem resistance in Enterobacterales
por: Cartagena, Alexis Jaramillo, et al.
Publicado: (2023)

Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial
por: Marín-Candón, Alicia, et al.
Publicado: (2021)

Bringing new tools, a regional focus, resource-sensitivity, local engagement and necessary discipline to mental health policy and planning
por: Atkinson, Jo-An, et al.
Publicado: (2020)

Cytoreductive Nephrectomy: Still Necessary in 2021
por: Méjean, Arnaud, et al.
Publicado: (2022)

Ceftazidime-Avibactam as Salvage Therapy in Pediatric Liver Transplantation Patients with Infections Caused by Carbapenem-Resistant Enterobacterales
por: Wang, Weili, et al.
Publicado: (2022)

Can animal data translate to innovations necessary for a new era of patient-centred and individualised healthcare? Bias in preclinical animal research
por: Green, Susan Bridgwood
Publicado: (2015)

Analysis of colistin resistance in carbapenem-resistant Enterobacterales and XDR Klebsiella pneumoniae
por: Bir, Raunak, et al.
Publicado: (2022)

Aztreonam-avibactam: an option against carbapenem-resistant Enterobacterales with emerging resistance
por: Wu, Shikai, et al.
Publicado: (2022)

Molecular characterization of clinical carbapenem-resistant Enterobacterales from Qatar
por: Abid, Fatma Ben, et al.
Publicado: (2021)

Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016–2018
por: Paveenkittiporn, Wantana, et al.
Publicado: (2021)

Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia
por: Alraddadi, Basem M., et al.
Publicado: (2022)

Monitoring Carbapenem-Resistant Enterobacterales in the Environment to Assess the Spread in the Community
por: Urase, Taro, et al.
Publicado: (2022)

Early Years of Carbapenem-Resistant Enterobacterales Epidemic in Abu Dhabi
por: Pál, Tibor, et al.
Publicado: (2022)

Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure
por: Rebold, Nicholas, et al.
Publicado: (2023)

Carbapenem-Resistant and ESBL-Producing Enterobacterales Emerging in Central Texas
por: Parker, Jennifer K, et al.
Publicado: (2023)

A Review of Carbapenem Resistance in Enterobacterales and Its Detection Techniques
por: Caliskan-Aydogan, Oznur, et al.
Publicado: (2023)

1839. Impact of Hypoalbuminemia on Ceftriaxone Treatment Failure in Patients With Enterobacterales Bacteremia
por: Steere, Evan, et al.
Publicado: (2022)

Con: Alzheimer's disease and circadian dysfunction: chicken or egg?
por: Moghekar, Abhay, et al.
Publicado: (2012)

No space left for intravenous thrombolysis in acute stroke: CONS
por: Muir, Keith
Publicado: (2016)

Is shorter always better? The pros and cons of treating Gram-negative bloodstream infections with 7 days of antibiotics
por: Yahav, Dafna, et al.
Publicado: (2022)

2477. Characteristics of patients infected with Carbapenem-resistant Acinetobacter baumannii complex and Carbapenem-resistant Enterobacterales in Tennessee, 2016–2021
por: Patel, Dipen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d26ko6uv7cj63iljc0c6ikb5ri